In-building Wireless Market Poised for Substantial Growth from 2024 to 2034

The in-building wireless market is expected to see robust growth over the next decade, with sales projected to increase from a current valuation of USD 14.77 billion in 2024 to an estimated USD 27.22 billion by 2034. This growth is driven by the increasing need for enhanced indoor coverage, public safety communication systems, and the rise of smart building technologies. The sector is benefiting from a convergence of technological advancements and the proliferation of digital infrastructure aimed at transforming in-building communications.

Key Takeaways from Market Study

  • The in-building wireless market is forecasted to grow at a CAGR of 6.3% between 2024 and 2034.
  • By 2034, the market is projected to reach a value of USD 27.22 billion.
  • Growing public safety concerns and demand for uninterrupted connectivity are driving adoption across commercial and residential buildings.
  • Advancements in smart building technologies and networking solutions are expected to significantly contribute to market growth.
  • North America and Asia-Pacific are leading regions in market adoption, reflecting strong growth potential due to rapid urbanization and smart city initiatives.

Drivers and Opportunities

The primary driver of growth in the in-building wireless market is the need for consistent and clear network coverage in high-density urban areas. This demand is heightened by the increased need for public safety systems within buildings, allowing for reliable communication during emergencies. Additionally, the rapid digitalization of industries and the growing implementation of smart building technologies are fueling investment in in-building wireless solutions. These systems support seamless communication, IoT integrations, and connectivity management across multiple platforms, creating an expansive opportunity for market players.

Components Insights

In-building wireless solutions consist of key components such as antennas, distributed antenna systems (DAS), small cells, and repeaters, which work together to ensure effective indoor communication coverage. Among these, DAS holds a significant share, thanks to its effectiveness in providing uniform wireless coverage across large facilities. As urban structures grow more complex, innovations in small cells and repeaters are gaining momentum to provide high-speed, uninterrupted communication.

Picture background

Application Insights

The adoption of in-building wireless systems spans various sectors, including corporate offices, hospitality, retail, healthcare facilities, and government buildings. The corporate sector represents a significant share of the market as companies prioritize in-building wireless to facilitate communication and operational efficiency. Meanwhile, the healthcare industry has also emerged as a prominent segment, with wireless systems enabling real-time data exchange and critical communication across hospital floors.

Deployment Insights

In terms of deployment, hybrid deployments are experiencing strong demand, combining traditional DAS with small cell technology to deliver comprehensive coverage. The rise of cloud-managed solutions also supports remote monitoring and configuration, providing scalable solutions tailored to both large and small building structures.

Key Companies & Market Share Insights

Prominent players in the in-building wireless market include CommScope Inc., Corning Incorporated, Ericsson, Huawei Technologies Co., Ltd., and Samsung Electronics Co., Ltd. These companies collectively hold a significant share, with ongoing R&D investments aimed at enhancing system integration and cost efficiency.

Recent Developments

  • CommScope introduced its latest portfolio of 5G-enabled in-building wireless solutions to improve coverage across dense urban areas.
  • Corning has invested in advanced optical DAS solutions to support seamless network management within buildings.
  • Huawei launched a new generation of indoor 5G systems, emphasizing energy efficiency and scalability for modern buildings.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Intraocular Lymphoma Treatment Market Expected to Reach USD 2.3 Billion by 2033 at a CAGR of 6.7%

Intraocular Lymphoma Treatments Market
Intraocular Lymphoma Treatments Market

The global intraocular lymphoma treatment market is projected to achieve a valuation of USD 1.2 billion by the end of 2023, with a robust growth trajectory expected in the coming years. According to Future Market Insights, the market is anticipated to expand at a compound annual growth rate (CAGR) of 6.7%, reaching an estimated US$ 2.3 billion by 2033.

Intraocular lymphomas are rare malignancies characterized by a diverse range of clinical manifestations, making diagnosis particularly challenging. The complexity of these tumors has spurred advancements in diagnostic techniques and treatment protocols, contributing to the overall market growth. Increased awareness among healthcare professionals regarding the symptoms and risks associated with intraocular lymphoma is also playing a crucial role in early detection and management.

Key drivers behind the growth of the intraocular lymphoma treatment market include rising incidence rates, improved treatment options, and ongoing research efforts focused on understanding the disease better. Additionally, advancements in therapies, such as targeted treatments and immunotherapies, are enhancing patient outcomes and driving demand for innovative solutions in the market.

North America currently leads the market, supported by a strong healthcare infrastructure, significant investment in cancer research, and heightened awareness of ocular malignancies. Meanwhile, the Asia-Pacific region is emerging as a potential growth area, driven by increasing healthcare access and growing investment in oncology research.

As the intraocular lymphoma treatment market continues to evolve, industry stakeholders are expected to prioritize research and development, focusing on new therapies and improved diagnostic tools. The future of the intraocular lymphoma treatment market looks promising, with opportunities for enhanced patient care and advancements in the management of this complex disease.

2018 To 2022 Intraocular Lymphoma Treatment Market Demand Analysis Vs. Forecast 2023 To 2033

The global Intraocular lymphoma treatment market grew at a CAGR of 5.1% from 2018 to 2022, as per Future Market Insights, a provider of market research and competitive intelligence.

The increasing incidence of non-Hodgkin lymphoma globally is one of the major reasons propelling market expansion. Also, the aging population, which is more susceptible to these diseases, is propelling market growth.

The discovery of new immune checkpoint inhibitors, which stop proteins from joining together and strengthen T-cell responses against the cancer cells, is one example of a technical development that is fueling the expansion of the intraocular lymphoma market. As a result, the global Intraocular Lymphoma Treatment Market is expected to forecast a CAGR of 6.7% from 2023 to 2033.

A Full Report Overview

Key Companies Profiled

  • Celgene Corporation
  • Genentech Inc.
  • Gossamer Bio Inc.
  • Seagen Inc.
  • National Cancer Institute
  • Northwestern University
  • Astex Pharmaceuticals
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.

Key Segments Covered In The Intraocular Lymphoma Treatment Market Report

By Drug Class:

  • Methotrexate
  • Rituximab
  • Cisplatin

By Mode of Administration:

  • Injectable
  • Oral

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End User:

  • Hospitals
  • Specialty Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

MEA Biologics and Biosimilars Market Projected to Reach USD 875.6 Million by 2033 at a 5.5% of CAGR

MEA Biologics and Biosimilars Market
MEA Biologics and Biosimilars Market

The Middle East and Africa (MEA) biologics and biosimilars market is poised for substantial growth, with an expected valuation of US$ 512.6 million in 2023. The market is projected to expand at a compound annual growth rate (CAGR) of 5.5%, reaching approximately US$ 875.6 million by 2033. According to a recent study by Future Market Insights, adalimumab currently leads the drug segment, capturing about 36.7% of the market share in 2022.

Several factors are driving the growth of the biologics and biosimilars market in the MEA region. The rising prevalence of chronic diseases, increasing demand for cost-effective treatment options, and growing healthcare infrastructure are significant contributors to market expansion. As healthcare providers and patients seek effective therapies, the adoption of biologics and biosimilars continues to rise, offering alternatives to traditional medications.

Adalimumab, a monoclonal antibody used to treat various autoimmune conditions, remains a key player in the market, reflecting the increasing acceptance of biosimilars in the treatment landscape. The success of adalimumab highlights the potential for biosimilars to provide affordable and effective treatment options for patients.

North Africa and the Middle East are expected to drive growth in this market, supported by governmental initiatives to enhance healthcare access, investments in biotechnology, and collaborations with pharmaceutical companies.

As the biologics and biosimilars market continues to evolve, industry players are likely to focus on innovation, expanding their product portfolios, and enhancing patient access to these therapies. The future of the MEA biologics and biosimilars market looks promising, offering opportunities for improved patient outcomes and advancements in healthcare delivery across the region.

Sales Analysis of MEA Biologics and Biosimilar Market from 2017 to 2022 Vs Market Outlook for 2023 to 2033

The market value for MEA biologics and biosimilar market was approximately 3.1% of the overall ~US$ 15.4 Billion global biologics and biosimilar market in 2021.

The most common cancers are breast cancer, lung and bronchus, colon and rectum, prostate, stomach, liver, cervix uteri, oesophagus, thyroid, and bladder.

to improve cancer patient care and ensure sure they have access to more effective, convenient, and affordable treatment options. MEA’s expansion in oncology innovation is being fuelled by a flurry of new, oncology–focused biotech businesses and increased cancer research.

due to the rising incidence of numerous cancers, the market for biosimilar drugs is anticipated to expand in this region.

Manufacturers of biologics are adopting various strategies to respond to potential entrants in biosimilars.

Pharmaceutical manufacturers are concentrating on ways to broaden and improve formulations, dosing, expression systems, and delivery mechanisms.

For MabThera, for instance, Roche created a novel subcutaneous formulation that reduces treatment time from 2.5 hours to 5 minutes. This can enhance patient adherence and healthcare results.

To remain competitive and ensure a robust product pipeline, leading biopharmaceutical companies are continuing to focus on the development of innovative drugs associated with regular treatments and technologically advanced healthcare solutions to increase the adoption rate.

What are the Key Opportunities for the Manufacturers Operating in MEA Biologics and Biosimilar Market?

Ustekinumab surpassed other medications in terms of annual increases in medical inflation-adjusted prices. Innovative strategies, such as the creation of biosimilars to improve patient access to care, are essential for reducing cost growth above inflation.

Global industry leaders are developing extended indications for already licensed biologics. The strategic approach involves the extension of the indication by conducting additional clinical investigations on the licensed biologics candidate.

The most advanced portfolios of biologics and biosimilars are held by early market leaders including AbbVie, Eisa Co Ltd., and Janssen Pharmaceuticals, a division of Johnson & Johnson.

According to WHO (2022), Non-communicable disease mortality is dramatically increasing in Middle Eastern and African (MEA) nations. 74% of all deaths in MEA are caused due to non-communicable diseases, which cause more than 38 million deaths annually worldwide.

Competitive Landscape

The leading players invest in several product launches, expansions, partnerships, mergers, and acquisitions to increase their market share globally and enhance their business strategies. The major companies in the MEA biologics and biosimilar market have embraced these as their top–tier primary promotional methods.

  • Abbott Operations Uruguay S.R.L. and Shanghai Henlius Biotech, Inc. announced their semi-exclusive licencing agreement in May 2022 for the marketing of Henlius’ independently developed HANLIKANG (rituximab) and HANQUYOU (trastuzumab, also known as Zercepac® in Europe) in Brazil.
  • Ligand Pharmaceuticals Corporation (Ligand) acquire Pfenex Inc. (Pfenex) in September 2020. Pfenex is a producer of biosimilar medications such teriparatide, ranibizumab, and pegfilgrastim.

Hikma Pharmaceuticals announced in July 2022 that it has signed a marketing agreement for Celltrion’s YuflymaTM drug.

Key Companies Profiled

  • AbbVie Inc.
  • Eisai Co Ltd
  • Zydus Cadila(Cadila Healthcare)
  • Amneal Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Celltrion, Inc.
  • Coherus BioSciences, Inc.
  • F. Hoffmann–La Roche Ltd (Genentech, Inc.)
  • Alexion(Astrazeneca)
  • Johnson & Johnson
  • Amgen
  • Hikma pharmaceuticals plc.

A Full Report Overview

Key Market Segments Covered in MEA Biologics and Biosimilar Industry Research

Drug:

  • Adalimumab
  • Bevacizumab
  • Trastuzumab
  • Ustekinumab
  • Golimumab
  • Eculizumab
  • Rituximab

Drug Class:

  • Antirheumatics
  • TNF Alfa Inhibitors
  • VEGF/VEGFR Inhibitors
  • HER2 Inhibitors
  • Selective Immunosuppressant’s
  • Interleukin Inhibitors

Dosage Form:

  • Subcutaneous
  • Intravenous

Indication:

  • Cancer
  • Arthritis
    • Rheumatoid
    • Psoriatic
    • Others
  • Skin Disorders
    • Plaque-Type Psoriasis
    • Hidradenitis Suppurativa
  • Inflammatory Bowel Disease (IBD)
    • Crohn’s Disease
    • Ulcerative Colitis
  • Rare Disease
  • Others

Distribution Channel:

  • Hospitals
    • Specialty Clinics
    • Cancer Research Centers
  • Retail Sales
    • Retail Pharmacies
    • Mail Order Pharmacies /Online Sales

Country:

  • UAE
  • Bahrain
  • Iraq
  • Jordan
  • Kuwait
  • Lebanon
  • Oman
  • Qatar
  • KSA
  • Iran
  • Palestine

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Gas Insulated Substation Market Anticipated to Reach USD 24.6 Billion by 2033, Growing Steadily at 5.4% CAGR | FMI Study

The global gas insulated substation market is poised for significant expansion, starting from an estimated value of USD 14.6 billion in 2023, according to a comprehensive analysis conducted by Future Market Insights (FMI). Projections indicate substantial growth ahead, with the market expected to achieve a valuation exceeding USD 24.6 billion within the next decade, driven by a robust Compound Annual Growth Rate (CAGR) of 5.4%.

This upward trajectory is primarily attributed to the rising demand for compact, low-maintenance power systems. Gas insulated substations are increasingly being recognized as a superior alternative to their air-insulated counterparts, offering heightened reliability and efficiency. This transformative trend underscores the industry’s steadfast commitment to addressing evolving energy demands through innovative and dependable solutions.

Browse Full Report Here

Market Drivers and Challenges in the Gas-Insulated Substation Landscape:

The gas-insulated substation market is on an expansion trajectory, driven by the escalating value of per-hectare land. These substations’ space-efficient design demands significantly less room than conventional counterparts, requiring merely 10% of the installation area. This compact footprint is a compelling factor propelling market growth.

Globally, the momentum has swung toward investments in clean and renewable energy ventures. This transition, coupled with burgeoning renewable projects and heightened electricity consumption, positions the gas-insulated substation market for a promising future, teeming with potential.

Key Drivers:

  1. Adaptability and Compactness: The market is set to burgeon over the next seven years owing to the soaring demand for adaptable solutions that can seamlessly fit within diverse structures. The ascendancy of compact power systems is expected to steer global market expansion, while the substation’s resilience in challenging environments like arctic or desert regions is poised to amplify its market footprint.

Key Insights:

  1. U.S. Dominance: Throughout the forecast period, the U.S. is projected to capture the lion’s share of the global gas-insulated substation market. This leadership is attributed to regional industry leaders adept at tailoring designs to meet operational requisites, ensuring cost-efficiency without compromising stability or employee well-being.
  2. Asia Pacific Ascendancy: The Asia Pacific region, spearheaded by China and Japan, is poised to claim the highest market share. Market players in this region have notably introduced phase-separated and enclosed type GIS solutions that exemplify compactness and robust construction, fortified by years of expertise.
  3. Indoor Installation Prowess: The “indoor” installation category is anticipated to command the lion’s share of revenue throughout the forecast period. Its versatility to be placed in confined spaces, residential zones, and industrial complexes—coupled with its portability—positions it as a dominant revenue generator.

Key Players:

  • General Electric Company
  • Hitachi Ltd.
  • ABB Ltd.
  • Larsen & Toubro Limited
  • Siemens AG
  • Mitsubishi Electric Corporation
  • Eaton Corporation PLC
  • Toshiba Corp
  • CG Power and Industrial Solutions Ltd
  • Schneider Electric SE
  • Bharat Heavy Electricals Limited
  • Elsewedy Electric Co S.A.E.
  • Powell Industries Inc.
  • Hyosung Corp

Recent Developments:

  • In November 2018, ABB has been granted a contract by German grid operator TransnetBW for an electrical substation upgrade. ABB is responsible for installing the world’s first 380kV gas-insulated switchgear under the $40 million contract.
  • In 2020, The Hitachi ABB Power Grids joint venture was formed by Hitachi Ltd. The new business is anticipated to offer financial power to support ambitious projects and new commercial potential as the sector embraces decentralization and digitization.

Key Segments Profiled in the Gas Insulated Substation Market Survey:

By Basis of Installation:

  • Indoor
  • Outdoor

By Voltage Rating:

  • Medium Voltage (Up to 72.5 kV)
  • High Voltage (72.5 kV – 220 kV)
  • Ultra-High Voltage (220 kV – 765 kV)

By End User:

  • Power Transmission & Distribution
  • Manufacturing & Processing

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Middle East and Africa (MEA)
  • Europe

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Africa’s Zero Liquid Discharge System Market Set to Reach US$ 53.1 Million by 2033, With a 5.6% CAGR

The Africa’s zero liquid discharge (ZLD) system market is poised for remarkable growth, with projections indicating substantial expansion in the coming years. In 2022, the market was valued at an impressive US$ 29.2 million, and this is just the beginning of a promising journey. The demand for ZLD systems is expected to remain consistently high throughout the assessment period, largely attributed to the rapid development of the industrial sector.

By 2023, the ZLD market in Africa is estimated to secure US$ 30.8 million, reflecting the sustained demand for these innovative wastewater treatment solutions. However, the real growth story unfolds as we look ahead to 2033. Projections suggest that the market will soar to an impressive US$ 53.1 million, registering a robust Compound Annual Growth Rate (CAGR) of 5.6% from 2023 to 2033.

This anticipated growth is driven by several key factors. One significant factor is the burgeoning industrial sector in Africa. As industries continue to expand and evolve, the need for efficient wastewater management becomes paramount. ZLD systems offer a sustainable and eco-friendly solution, allowing industries to minimize their environmental footprint while meeting stringent regulatory requirements.

Browse Full Report Here

– Market Insights by Region: A Focus on Zero Liquid Discharge Systems

South Africa’s Growth Trajectory: A Spotlight on Zero Liquid Discharge System Sales

Exploring the Impact of Industrial Advancements on Market Dynamics

In the realm of sustainable solutions, the zero liquid discharge system market in South Africa is poised to exhibit a commendable upswing, showcasing a projected Compound Annual Growth Rate (CAGR) of 5.5% across the forecast period. This upward trajectory can be attributed to the unfolding developments within key industrial bastions. Among these, the pharmaceutical, mining & metallurgy, and chemicals & petrochemical sectors stand prominent, harboring both tier-1 conglomerates and enterprises at the lower tiers. A noteworthy trend within this landscape is the prevalence of customized zero liquid discharge systems being offered as part of operational strategies.

Northern Africa’s Quest: Unveiling the Thrust Behind Zero Liquid Discharge Systems Demand

– A Glimpse into Amplified Market Sales Driven by Industrial Appetite

In the expanse of Northern Africa, the zero liquid discharge system market is gearing up to capture a substantial 40% stake in the regional market panorama. This ascent is underpinned by a robust projected CAGR of 5.6% throughout the evaluation span. The catalyst for this dynamic growth is rooted in the escalating demands stemming from various end-use industries. Among the most influential contributors are the chemicals, petrochemicals, mining, leather, and textile sectors. The confluence of increased production in these domains is set to galvanize the requisition for zero liquid discharge systems, carving out lucrative avenues for stakeholders in the market ecosystem.

Namibia’s Trajectory: A Deep Dive into Zero Liquid Discharge System Applications

– Exploring the Chemical Sector’s Dominance in Orchestrating Market Expansion

Within the captivating landscapes of Namibia, the proliferation of zero liquid discharge systems finds its stronghold within the realms of mining & metallurgy, chemicals, and paper industries. This triad of applications assumes the role of prime drivers propelling the demand for innovative zero liquid discharge systems. What further accentuates this surge is the hallmark of tailored solutions and resilient post-sales services, meticulously curated by key market protagonists. As the chemical industry unfurls its wings, it inherently propels the growth trajectory of the zero liquid discharge system market in Namibia, marking a strategic alignment of industry evolution and sustainable practices.

-Key Players:

  • Veolia
  • SUEZ
  • GEA Group
  • ANDRITZ AG
  • Thermax Global Limited
  • IDE Technologies
  • Alfa Laval AB
  • Multotec Group
  • Condorchem Envitech
  • Cannon S.p.A.
  • Ion Exchange India Limited

– Market Segments by Category:

By System Type:

  • Conventional
  • Hybrid

By Application:

  • Power Generation
  • Oil & Gas
  • Chemicals & Petrochemicals
  • Mining & Metallurgy
  • Pharmaceuticals
  • Food
  • Textile & Leather
  • Paper
  • Others

By Country:

  • Northern Africa
  • Egypt
  • Morocco
  • Algeria
  • Tunisia
  • East & West Africa
  • Ethiopia
  • Kenya & Tanzania
  • Nigeria
  • Ghana
  • Senegal
  • Southern Africa
  • Angola
  • Zimbabwe
  • Namibia
  • Mozambique
  • South Africa

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: mailto:sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

FMI Projects Global Heat Shrink Tubing and Sleeves Market Anticipated to Exceed USD 3,865 Million Revenue by 2033, Growing at 6.2% CAGR

The global heat shrink tubing and sleeves market, with a valuation of USD 1,995 million in 2022, is experiencing sustained growth, projected to reach USD 2,118 million in 2023. This market has garnered significant attention for its anticipated substantial expansion. Projections indicate a remarkable surge, with the market expected to exceed USD 3,865 million by 2033, propelled by a robust Compound Annual Growth Rate (CAGR) of 6.2% from 2023 to 2033.

A primary driver behind this exceptional growth is the rapid pace of urbanization and the expanding global population. As cities evolve to accommodate a growing number of residents and businesses, there is a corresponding increase in demand for reliable electrical distribution infrastructure. The escalating construction and development activities, spanning both residential and commercial projects, significantly contribute to the robust market demand for heat shrink tubing and sleeves. This highlights their pivotal role in advancing infrastructure development on a global scale.

Driving Forces Behind Heat Shrink Tubing and Sleeves Market Growth:

The rapid evolution within global industrial sectors, accompanied by substantial investments in mechanical equipment, stands as pivotal drivers of the surging demand for heat shrink tubing and sleeves. Additionally, the provision of tailored solutions and the strategic expansion of distribution channels by Original Equipment Manufacturers (OEMs) will consistently fuel the growth trajectory of this market in the foreseeable future.

Environmental Concerns Stimulate Product Innovations:

Heightened environmental awareness in various countries is instigating advancements in the global heat shrink tubing and sleeves market. Both consumers and manufacturers are exhibiting a growing preference for cost-effective eco-friendly alternatives and recycled plastic products. This trend is creating an avenue for key market players to diversify their product portfolios and tap into expanding market segments.

Key Insights from the Heat Shrink Tubing and Sleeves Market Survey:

  1. U.S. Dominance in North America: With influential market players and escalating demand across diverse industries, the U.S. is poised to account for approximately 67% of the North American heat shrink tubing and sleeves market.
  2. China’s Prominent Emergence: Rapid expansion in the electric and electronic sectors positions China as the frontrunner in the heat shrink tubing and sleeves market.
  3. Europe’s Sizeable Market Share: According to FMI, Europe is anticipated to secure a substantial 21.4% share of the global heat shrink tubing and sleeves market.
  4. Energy Sector Impact: Driven by the expansion of the energy sector and heightened oil and gas activities, the energy segment is forecasted to account for around 14.9% of the global heat shrink tubing and sleeves market in 2021.
  5. Concentration Among Top Players: The top five players in the heat shrink tubing and sleeves market are projected to collectively hold an estimated 52% of the total market share.

Competitive Landscape: Innovations and Collaborations Drive Heat Shrink Tubing and Sleeves Market

Key players within the heat shrink tubing and sleeves market are strategically amplifying their product portfolios through significant investments in research and development endeavors. They are effectively harnessing both organic and inorganic growth avenues, including mergers and acquisitions, novel product introductions, partnerships, and collaborations, all aimed at fortifying their global presence.

Noteworthy Illustration of Innovation:

In September 2020, TE Connectivity, a frontrunner in connectivity and sensors, unveiled a range of UV-SCE printable heat shrink sleeves designed for wire and cable identification in settings with potential UV light exposure.

Leading Market Players Identified by FMI:

  1. HellermannTyton
  2. Molex Electronic Solutions
  3. Panduit
  4. Shrink Sleeves Ltd.
  5. TE Connectivity
  6. ABB Ltd.
  7. The 3M Company
  8. Wurth Elektonik Company
  9. Techflex
  10. Artilabo International
  11. Gremtek SAS
  12. PEXCO
  13. DSK-CANUSA
  14. WKK Nederland’s B.V.
  15. Essentra PLC
  16. Plastpolymer Prom LLC
  17. Don-Polymer Ltd.

Market Segments:

By Material Type:

  • Polyolefin (POE)
  • Ethylene Vinyl Acetate (EVA)
  • Polytetrafluoroethylene (PTFE)

By Length:

  • Spool
  • Standard (1.2 Meter)

By Product Type:

  • Tubes
  • Sleeves

By Sales Channel:

  • Original Equipment Manufacturer (OEM)
  • Aftermarket

By Applications:

  • Automotive
  • Aerospace
  • Railways

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa

Access Report Details for More Information:

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ultra Short Base Line Positioning Systems Market Value Soars to USD 256.8 billion by 2033, With a 6.0% CAGR

The global Ultra Short Base Line Positioning Systems Market is projected to reach a value of USD 135.3 million in 2022, with sustained demand expected for bridge expansion joints throughout the assessment period. Notably, the escalating demand for offshore equipment is poised to drive significant growth, reaching a remarkable valuation of USD 256.8 billion by 2033, with a noteworthy Compound Annual Growth Rate (CAGR) of 6.0% from 2023 to 2033. Anticipated market figures suggest a securement of USD 143.4 million in 2023.

Although recent years have witnessed sluggish growth patterns, this trend can be attributed to the availability of more cost-effective acoustics and the reliability of associated technologies. Notably, the installation of ultra-short baseline positioning systems on newer boats and yachts has become increasingly prevalent in countries such as the United Arab Emirates, Singapore, and Thailand. This installation trend serves to enhance safety standards, making deep-sea diving activities a burgeoning tourist attraction in these regions.

Browse Full Report Here

Growth Factors

Ultra-short baseline systems find key applications across a diverse array of end users, including researchers, surveyors, naval operations, and recreational businesses. These systems cater to a multitude of activities ranging from underwater photography to marine research, among others.

Manufacturers have responded to this demand by integrating wireless data transmission capabilities into these systems, effectively reducing overall operational costs. However, despite these advancements, any onboard failure or malfunction during expeditions necessitates the operator to halt work and return to the docks, resulting in both time and financial losses.

In regions such as Indonesia, Singapore, the United Arab Emirates, and Thailand, ultra-short baseline positioning systems have been adopted for precautionary and safety measures in recreational activities. For years, the option of inverting an ultra-short baseline positioning system has been viewed as advantageous in terms of operational efficiency, particularly in deep tow fish tracking applications, when compared to conventional ultra-short baselines.

Key Companies

  • Kongsberg Maritime AS
  • Teledyne Marine
  • iXblue
  • ROV-Support A/S
  • EvoLogics GmbH
  • Sonardyne Holdings Limited
  • AAE Technologies Ltd.
  • Tritech International Limited
  • Imenco AS
  • Deep Trekker Inc.
  • VideoRay LLC
  • Link Quest Inc.
  • Blueprint Design Engineering Ltd.
  • Beringia Enterprises LLC (DiveNET)

Market by Category

By Operating Frequency Range:

  • 14-18 kHz
  • 20-30 kHz

By Nominal Range:

  • Shallow (up to 150 m)
  • Medium (upto 1,000 m)
  • Deep (up to 10,000 m)

By Antenna Aperture:

  • 70 Degree
  • 100 Degree
  • 200 Degree

By End User:

  • Offshore Equipment Positioning
  • ROV, AUV vessel positioning
  • Cartography
  • Diver Tracking
  • Naval SAR vessels
  • Underwater Photography/Cinematography
  • Tourism & Leisure
  • Marine Sciences

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Migraine Treatment Market Projected to Reach USD 4.74 Billion by 2033 at a 4% of CAGR

Acute Migraine Treatment Market
Acute Migraine Treatment Market

The global migraine treatment market is anticipated to achieve a valuation of USD 3.2 billion in 2023 and is expected to grow to approximately USD 4.74 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4% during the forecast period from 2023 to 2033. The market demonstrated a steady growth rate of 3% in the historical period from 2018 to 2022.

The rising prevalence of migraines and increasing awareness about effective treatment options are significant drivers behind the growth of the migraine treatment market. As awareness of migraine as a chronic condition continues to expand, patients are more likely to seek treatment, thereby increasing demand for various therapeutic options.

Advancements in migraine therapies, including new medications and innovative treatment protocols, are also contributing to market growth. The introduction of preventive treatments and personalized medicine approaches is expected to enhance patient outcomes and satisfaction, further fueling market expansion.

North America currently dominates the migraine treatment market, supported by a well-established healthcare system, significant investment in research and development, and high patient awareness. Meanwhile, the Asia-Pacific region is emerging as a high-growth area, driven by rising healthcare expenditures, increasing access to treatment options, and growing patient education initiatives.

As the demand for effective migraine treatments continues to rise, industry players are expected to focus on research and innovation, developing new therapies, and improving access to existing treatments. The future of the migraine treatment market looks promising, with opportunities for enhanced patient care and improved quality of life for individuals suffering from migraines.

Which are Some Prominent Drivers of the Migraine Treatment Market?

Growing advancements in diagnostic and treatment options to push the market growth

The global Migraine Treatment market is primarily driven by an increased prevalence of Migraine, which is driving the demand for effective treatments. According to the Migraine Research Foundation, migraine is the third most common disease in the world, affecting an estimated 1 billion people globally. This large patient population represents a significant market opportunity for companies developing migraine treatments.

In recent years, there has been a growing focus on developing targeted therapies that can provide more effective and personalized treatment for migraine patients. For example, new monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway have been shown to be highly effective in preventing migraines in some patients.

Additionally, the growth of the Migraine Treatment market is owed to ongoing research and development, which is leading to an increased potential for new and improved treatment options to become available for patients with Migraine. There is a growing investment in research and development of treatments for Migraine, with many biotech and pharmaceutical companies working on developing new gene therapies for these conditions.

For instance, in February 2022, Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Rimegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist. It is recommended as the 75 mg dose of Rimegepant (available as an orally dissolving tablet) for marketing authorization for both the acute treatment of migraine with or without aura in adults and the preventive treatment of episodic migraine in adults who have at least four migraine attacks per month.

Market Competition

Key players in the market include companies such as Lundbeck Seattle BioPharmaceutical, Eli Lilly and Company, Amgen, Novartis, Allergan, Teva Pharmaceuticals, Biohaven Pharmaceuticals, Biohaven Pharmaceuticals, Dr. Reddy’s Labs, AbbVie, Impel NeuroPharma, Zosano Pharma, Aeon Biopharma Inc., Ionis Pharmaceuticals, Inc., and Charleston Laboratories, along with healthcare providers and technology companies among other global players.

  • In January 2022, BioDelivery Sciences launched a new drug, Elyxyb (celecoxib oral solution), a fast-acting liquid. It is one of the first Food and Drug Administration-approved ready-to-use oral solutions for adults in the acute treatment of migraine, with or without aura.
  • In September 2021, AbbVie received FDA approval for QULIPTA™ (atogepant), the first oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) specifically designed to prevent episodic migraine in adults. QULIPTA is an oral medication that can help reduce monthly migraine days with a once-daily dosage that works quickly and continuously. AbbVie is proud to offer three products for the complete spectrum of migraine treatment, including preventive therapies for chronic and episodic migraine and an acute treatment for migraine attacks. This approval is backed by a clinical program that evaluated the safety, tolerability, and effectiveness of QULIPTA in almost 2,000 patients who experienced 4 to 14 migraine days per month, including the Phase 3 ADVANCE study, the Phase 2b/3 study, and the Phase 3 long-term safety study.

Key Companies Profiled

Lundbeck Seattle BioPharmaceutical, Eli Lilly and Company, Amgen, Novartis, Allergan, Teva Pharmaceuticals, Biohaven Pharmaceuticals, Biohaven Pharmaceuticals, Dr. Reddy’s Labs, AbbVie, Impel NeuroPharma, Zosano Pharma, Aeon Biopharma Inc., Ionis Pharmaceuticals, Inc., and Charleston Laboratories

A Full Report Overview

Key Segments Profiled in the Migraine Treatment Industry Survey

Drug Class:

  • Zavegepant
  • Atogepant
  • Zolmitriptan

Route of Administration:

  • Oral
  • Parenteral
  • Nasal Sprays

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Treatment:

  • Abortive Medicine
  • Preventive Medicine

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Industrial Vacuum Evaporation Systems Market Anticipated to Reach US$ 5.8 billion Mark by 2033, Driving 7.5% CAGR Growth

The global industrial vacuum evaporation systems market is positioned for steady growth, with a projected valuation of US$ 5.8 billion by 2033. This expansion is anticipated to occur at a Compound Annual Growth Rate (CAGR) of 7.5% from a 2023 market size of USD 2.58 billion.

Industrial vacuum evaporation systems are a key driver of this growth, holding a significant 58% share of the global vacuum evaporation systems industry revenue in 2020. This dominant position highlights the effectiveness and adaptability of these systems, making them crucial tools across various industries worldwide.

Browse Full Report Here

With the surge in environmental consciousness, there is a heightened demand for industrial vacuum evaporation systems that effectively handle wastewater treatment and contribute to reducing industrial waste output.

Over recent years, there has been a significant upswing in global industrial activity, amplifying the need for industrial equipment on a global spectrum.

Key Insights:

  • Within North America, the United States prominently occupies the market front with a substantial market share of 26.0% recorded in 2022. This achievement is primarily underpinned by the resurgence of industrial activities, manufacturing resurgence, and expansion of production facilities.
  • Germany emerges as another noteworthy contender in the European industrial vacuum evaporation systems market, holding a commendable market share of 5.9% in 2022. This growth is attributed to the concerted efforts of the government alongside increased research and development endeavors.
  • In the Indian market, industrial vacuum evaporation systems exhibit remarkable growth, registering a compelling Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period. This robust expansion is propelled by the proliferation of industrial facilities and heightened foreign investment.
  • Among system types, the rotary evaporator segment assumes a leading stance, commanding a notable market share of 31.8% in 2023. This growth owes itself to the elevated consumption levels observed.
  • Within application segments, the wastewater treatment & recycling sector emerges triumphant, wielding a dominant market share of 34.0% in 2023. This prominence is a direct result of concerted governmental initiatives focused on addressing wastewater concerns.

Competition Landscape:

Manufacturers of industrial vacuum evaporation systems are actively prioritizing the introduction of novel and advanced products to effectively address evolving application demands. These companies are strategically embracing both organic and inorganic approaches to bolster their global market footprint.

Recent Industry Advancements:

Renowned industrial equipment manufacturer, SP Scientific, unveiled an innovative line of evaporators – the HT Series 3i Evaporators. Notably, these upgraded models are characterized by enhanced user-friendliness and eco-conscious design, optimizing the evaporation process for improved productivity.

Competitive Outlook:

Key contenders in the field focus on facilitating seamless installation processes, ensuring operational efficiency, and maintaining competitive pricing strategies. These competitors further leverage collaborations, acquisitions, and partnerships to enhance their supply chains and distribution networks, solidifying their market position.

Key Players:

  • GEA Group
  • SUEZ
  • Veolia
  • PRAB
  • BÜCHI Labortechnik AG
  • GEMÜ Group
  • Heidolph Instruments GmbH & CO. KG
  • S.A.I.T.A SRL
  • WIGGENS GmbH
  • IWE SRL
  • Condorchem Envitech
  • ENCON Evaporators
  • Eco-Techno SRL
  • Sanshin Mfg. Co. Ltd.
  • EYELA

Market Segmentation:

By Application:

  • Wastewater Treatment & Recycling
  • Solvent Recycling & Purification
  • Distillation
  • Synthesis
  • Concentration
  • Drying
  • Recrystallization

By System:

  • Mechanical Vapour Recompression Evaporators
  • Heat Pump Evaporators
  • Co-Generation Hot & Cold Evaporators
  • Rotary Evaporators
  • Thermal Evaporators
    • Multiple Effect
    • Single Effect

By Capacity:

  • Up to 100 Ltr/Day
  • 150 to 500 Ltr/Day
  • 500 to 1000 Ltr/Day
  • 1000 to 2000 Ltr/Day
  • 2000 to 4000 Ltr/Day
  • 4000 to 8000 Ltr/Day
  • 8000 to 20000 Ltr/Day
  • 20000 to 50000 Ltr/Day

By End-use Industry:

  • Pharmaceuticals
  • Chemicals
  • Metallurgy
  • Printing & Textiles
  • Oil & Petrochemicals
  • Food & Beverages
  • Semiconductors
  • Power Generation
  • Medical & Research Laboratories

Key Regions Covered:

  • North America
    • United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Japan
  • Asia Pacific Excluding Japan
    • China
    • India
    • Malaysia
    • Singapore
    • Australia
    • Rest of Asia Pacific Excluding Japan (APEJ)
  • The Middle East and Africa
    • GCC Countries
    • Israel
    • South Africa
    • The Middle East and Africa (MEA)

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Glucose Monitoring Devices Market Set to Surge to USD 44.6 Billion by 2034 at a 10.6% of CAGR Amid Rising Diabetes Prevalence

Glucose Monitoring Devices Market
Glucose Monitoring Devices Market

As the global burden of diabetes continues to grow, the need for accurate and efficient glucose monitoring becomes increasingly critical for effective management of the condition. In response to this rising demand, the global market for glucose monitoring devices is projected to experience significant growth, with an anticipated compound annual growth rate (CAGR) of 10.6% over the next decade.

According to Future Market Insights’ updated report, the market value for glucose monitoring devices is expected to increase from US$ 16.2 billion in 2024 to US$ 44.6 billion by 2034. Following a valuation of US$ 14.7 billion at the end of 2023, the market is set to demonstrate a year-on-year growth rate of 10.3% in 2024.

The rising prevalence of diabetes is a key driver behind this robust market growth. The International Diabetes Federation (IDF) estimates that diabetes will impact approximately 643 million people by 2030 and 783 million by 2045. This alarming increase in diabetes cases is creating a conducive environment for the development and adoption of advanced blood sugar monitoring devices.

Key factors contributing to market expansion include technological advancements in glucose monitoring systems, the rising awareness of diabetes management, and a growing emphasis on preventive healthcare. As healthcare providers and patients alike recognize the importance of effective glucose monitoring in managing diabetes, the market is poised for sustained growth.

The future of the glucose monitoring devices market looks promising, with opportunities for innovation and enhanced patient care. Industry players are expected to focus on developing user-friendly devices, integrating digital health technologies, and improving accessibility to ensure that individuals living with diabetes can effectively monitor and manage their condition.

Glucose Monitoring Device Market Overview

The glucose monitoring device industry is experiencing robust growth due to investment in research and development (R&D) efforts. These efforts are aimed at propelling advances in device technologies such as wearable sensors, cloud-based platforms, and smartphone integration. They are aimed at pushing the boundaries of innovation within the field.

Advances in sensor technologies and AI integration are boosting the glucose monitoring product market. Sensor technologies are becoming increasingly smaller, allowing for more discreet and comfortable wear. Miniaturization also enables the integration of sensors into wearable devices, such as smartwatches and patches.

Patients, healthcare providers, and other stakeholders are increasingly seeking devices that offer improved accuracy, reliability, and usability. Manufacturers are responding to this demand by investing heavily in research and development to bring innovative products to market. As a result, we are witnessing a rapid evolution in the capabilities of blood sugar monitoring devices, with each new generation offering enhanced features and performance.

By pushing the boundaries of technology and innovation, key manufacturers in the market are propelling positive change in the healthcare landscape and empowering patients to manage their health better. This will bode well for the target market during the next ten years.

Competitive Landscape in Glucose Monitoring Device Market

In the constantly evolving glucose monitoring device industry, several opportunities exist. In order to capitalize, key companies are innovating to develop novel glucose measuring and monitoring solutions. For instance, some companies are looking to develop apps that connect to glucose monitoring solutions for remote and continuous glucose monitoring.

New product launches and approvals are gaining popularity in the market. Similarly, players are implementing strategies like mergers, partnerships, distribution agreements, collaborations, and acquisitions to boost their sales and stay ahead of the competition.

Recent Developments in Glucose Monitoring Product Market

  • In August 2023, ACON Laboratories, Inc., headquartered in the United States, made the On Call® MultiPro System available for point-of-care testing in healthcare settings, offering rapid and accurate results, multi-language support, and connectivity options.
  • In February 2024, United States-based DexCom, Inc., a prominent player in real-time continuous glucose monitoring for individuals with diabetes, introduced their latest CGM system, the Dexcom ONE+.
  • In March 2024, the United States Food and Drug Administration (FDA) approved the marketing of the first OTC continuous glucose monitor.

Key Players in the Glucose Monitoring Device Market

  • Abbott Laboratories
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd
  • Medtronic
  • LifeScan IP Holdings, LLC
  • Ascensia Diabetes Care Holdings AG.
  • ARKRAY, Inc.
  • ACON Laboratories, Inc.
  • NIPRO
  • Nova Biomedical
  • Ypsomed
  • Prodigy Diabetes Care, LLC.
  • ForaCare, Inc.
  • Trividia Health, Inc.
  • AgaMatrix
  • Beurer GmbH
  • All Medicus Co., Ltd.
  • HMD
  • Bioland Technology Limited.
  • OakTree-Health.com
  • Biosense Technologies Private Limited
  • Senseonics
  • Medtrum Technologies Inc.
  • Taidoc Technology Corporation
  • B. Braun SE

A Full Report Overview

Global Glucose Monitoring Device Market Segmentation

By Product:

  • Continuous Monitoring Devices
    • Monitors
    • Sensors
    • Transmitters
  • Self-monitoring Devices

By Indication:

  • Diabetes Type I
  • Diabetes Type II
  • Gestational Diabetes

By End-user:

  • Hospitals
  • Clinics
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube